Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Zoetis Inc.
  6. Summary
    ZTS   US98978V1035

ZOETIS INC.

(ZTS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/03/2021 05/04/2021 05/05/2021 05/06/2021 05/07/2021 Date
175.24(c) 173.77(c) 173.86(c) 167.52(c) 171.55(c) Last
1 886 845 1 849 739 1 433 524 3 200 090 1 482 519 Volume
+1.28% -0.84% +0.05% -3.65% +2.41% Change
More quotes
Financials (USD)
Sales 2021 7 597 M - -
Net income 2021 1 992 M - -
Net Debt 2021 2 981 M - -
P/E ratio 2021 41,8x
Yield 2021 0,53%
Sales 2022 8 063 M - -
Net income 2022 2 253 M - -
Net Debt 2022 1 938 M - -
P/E ratio 2022 36,3x
Yield 2022 0,61%
Capitalization 81 446 M 81 446 M -
EV / Sales 2021 11,1x
EV / Sales 2022 10,3x
Nbr of Employees 11 300
Free-Float 94,6%
More Financials
Company
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product... 
Sector
Pharmaceuticals
Calendar
05/20 | 09:00am
More about the company
Notations Surperformance© of Zoetis Inc.
Trading Rating : Investor Rating :
More Ratings
All news about ZOETIS INC.
05/07ZOETIS  : Barclays Adjusts Zoetis' Price Target to $208 From $200, Maintains Ove..
MT
05/07ZOETIS  : Raymond James Adjusts Zoetis' Price Target to $192 From $166, Maintain..
MT
05/06ZOETIS  : Management's Discussion and Analysis of Financial Condition and Result..
AQ
05/06ZOETIS  : Raises 2021 Guidance After First Quarter Beats Estimates on Strong Com..
MT
05/06GLOBAL MARKETS LIVE : Uber, AB Inbev, PayPal...
05/06Zoetis 1Q Beats Analyst Views
DJ
05/06Zoetis Raises 2021 Guidance
DJ
05/06Equities Signal Stronger Open as US Futures Rise Pre-Bell; Europe, Asia Trade..
MT
05/06ZOETIS  : Posts Increase in Q1 Adjusted Earnings, Revenue; Raises 2021 Outlook
MT
05/06Wall Street Edges Forward Pre-Bell; Futures Green, Europe Steady, Asia Higher
MT
05/06ZOETIS : Q1 Earnings Snapshot
AQ
05/06ZOETIS  : Posts Q1 Adjusted EPS of $1.26 vs. Street Forecast of $1.04
MT
05/06GUIDANCE : (ZTS) ZOETIS Expects Fiscal Year 2021 EPS Range $4.42 - $4.51
MT
05/06ZOETIS  : Posts Q1 Revenue of $1.87 Billion vs. Street Forecast of $1.73 Billion
MT
05/06ZOETIS INC.  : Results of Operations and Financial Condition (form 8-K)
AQ
More news
News in other languages on ZOETIS INC.
05/06STOCK MARKET PARIS : Tout augmente, mon pauvre monsieur
05/06EN DIRECT DES MARCHES  : Société Générale, ArcelorMittal, EssilorLuxottica, Air ..
02/16Londres et Paris dopées aux vaccins, aux cycliques et à Vivendi
02/16EN DIRECT DES MARCHES  : Michelin, TechnipFMC, Sanofi, Faurecia, Vicat, BHP, Gle..
2020EN DIRECT DES MARCHES  : ArcelorMittal, Société Générale, Veolia, CGG, Lufthansa..
More news
Analyst Recommendations on ZOETIS INC.
More recommendations
Chart ZOETIS INC.
Duration : Period :
Zoetis Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZOETIS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 184,25 $
Last Close Price 171,55 $
Spread / Highest target 22,4%
Spread / Average Target 7,40%
Spread / Lowest Target -17,2%
EPS Revisions
Managers and Directors
NameTitle
Kristin C. Peck Chief Executive Officer & Director
Glenn C. David Chief Financial Officer & Executive Vice President
Michael B. McCallister Non-Executive Chairman
Catherine Ann Knupp Executive VP, President-Research & Development
Wafaa Mamilli Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC.3.66%81 446
ELANCO ANIMAL HEALTH INCORPORATED7.21%15 546
DECHRA PHARMACEUTICALS PLC20.12%6 272
JINYU BIO-TECHNOLOGY CO., LTD.0.57%3 653
WUHAN KEQIAN BIOLOGY CO.,LTD-6.51%2 811
VIRBAC12.18%2 738